|
⚲
|
| Keyboard |
| Boyalife Asset Holding II Inc
✚
|
|
|---|---|
| CIK # | 0001738415 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001738415] | |
| 4 | [0001738415] | |
| SC 13D | [0001738415] |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed |
|---|---|---|
| Boyalife Asset Holding II Inc | Cesca Therapeutics Inc | [2018-04-27] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Cesca Therapeutics Inc | |
| Xu Xiaochun | |
| Boyalife Asset Holding II Inc | |
| Boyalife Group Inc | |
| Boyalife Hong Kong Ltd | |
| Li Yishu |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Cesca Therapeutics Inc THMO
Second Amended and Restated Convertible Note · derivative
|
2022-06-28 | Conversion | |||
|
Cesca Therapeutics Inc THMO
Common Stock
|
2022-06-28 | Conversion | 10,552,234 | $0.28 | 2,954,626 |
|
Cesca Therapeutics Inc THMO
Common Stock
|
2020-04-28 | Other | 621,637 | $1.80 | 1,118,947 |
|
Cesca Therapeutics Inc THMO
Common Stock
|
2020-02-13 | Conversion | 1,666,670 | $1.80 | 3,000,006 |
|
Cesca Therapeutics Inc THMO
Second Amended and Restated Convertible Note · derivative
|
2020-02-13 | Conversion | $0.00 | ||
|
Cesca Therapeutics Inc KOOL
Common Stock
|
2019-12-26 | Buy | 683,824 | $2,277,134.00 | 1,557,158,880,416 |
|
Cesca Therapeutics Inc KOOL
Common Stock
|
2019-12-26 | Buy | 683,824 | $2,277,134.00 | 1,557,158,880,416 |
|
Cesca Therapeutics Inc KOOL
Warrants to Purchase Common Stock · derivative
|
2019-12-26 | Buy | 352,942 | $10.00 | 3,529,420 |
|
Cesca Therapeutics Inc KOOL
Warrants to Purchase Common Stock · derivative
|
2019-12-26 | Buy | 352,942 | $10.00 | 3,529,420 |
|
Cesca Therapeutics Inc KOOL
Participation Interest in Convertible Note · derivative
|
2019-12-20 | Buy | $2,000,000.00 |